GlassScriptPhysician profile
Carl E Piersma
NPI 1093861593
$982.52
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $966 · 2022: $16.24.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $232.60 | 2021 | |
| Novo Nordisk INC | $115.36 | 2021 | |
| Lilly USA, LLC | $96.92 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $69.28 | 2021 | |
| Amgen INC. | $62.78 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $57.66 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $55.90 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $54.39 | 2021 | |
| Astellas Pharma US INC | $53.91 | 2021 | |
| Janssen Pharmaceuticals, INC | $36.43 | 2021 | |
| Philips North America LLC | $30.84 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $30.43 | 2021 | |
| Allergan, INC. | $19.87 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.83 | 2021 | |
| Novartis Pharmaceuticals Corporation | $16.24 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $15.59 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $14.49 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carl Piersma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.